Article
Safety and efficacy of peginterferon alpha plus ribavirin in patients with chronic hepatitis C and coexisting heart disease.
Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver - 1 May 2011
Durante-Mangoni Emanuele, Iossa Domenico, Pinto Daniela, De Vincentiis Lucia, Ragone Enrico, Utili Riccardo
Abstract excerpt
BACKGROUND: Chronic hepatitis C patients with coexisting heart disease are often denied antiviral treatment due to safety concerns. However, this is not evidence-based. AIMS: To evaluate safety and efficacy of pegylated interferon and ribavirin in chronic hepatitis C patients with heart disease....
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.